Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BSH 2024 | Women’s health post stem cell transplant

Maria Mazza-Beange • 24 Apr 2024
BSH 2024
General

Maria Mazza-Beange, BSc(Hons), University Hospital Bristol NHS Foundation Trust, Bristol, UK, briefly discusses women’s health post-stem cell transplant (SCT), which is likely not given sufficient attention in many centers. Treatment with high-dose chemotherapy and SCT is potentially inducing early menopause or primary ovarian insufficiency in female patients, and an emphasis should be placed on encouraging patients to have conversations with healthcare providers about the signs and symptoms they are experiencing so that appropriate care can be provided in a timely manner. This interview took place at the 64th Annual Scientific Meeting of the British Society for Haematology (BSH) Congress in Liverpool, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Related Videos

4:09
Veno-occlusive disease as a post-transplant complication of HSCT
Mohamad Mohty • 17 Apr 2024
1:56
Addressing access inequality in CAR-T therapies
Francesca Del Bufalo • 15 Apr 2024
1:34
The future role of AI models in hematology and the need for high-quality data sets
Thomas Coats • 29 Apr 2024
6:38
Key papers in cardio-oncology from 2023 of relevance to hematologists
Alexander Lyon • 25 Apr 2024
The content of VJHemOnc is intended for healthcare professionals